This content is machine translated Rheumatoid arthritis JAK inhibitor reduces pain for a long time Patients with active rheumatoid arthritis often suffer from considerable pain. Therefore, pain control is an important treatment goal in this patient group. In a post-hoc analysis of the FINCH studies…
View Post 4 min This content is machine translated SLE: Early use of biologics? Findings from the “Leeds SLE Inception Cohort” If systemic lupus erythematosus (SLE) cannot be adequately controlled with hydroxychloroquine and cortisone preparations, the use of immunomodulatory or immunosuppressive agents and/or biologics should be considered according to current EULAR…
View Post 8 min This content is machine translated Rheumatoid arthritis News on gender medicine in the RA Rheumatoid arthritis (RA) is the most common inflammatory rheumatic joint disease, affecting women 2-3 times more often than men. The exact interaction of immunological, hormonal and genetic factors has not… CME-Test
View Post 7 min This content is machine translated Interview with Prof. Thomas Kündig (USZ) and Prof. Diego Kyburz (USB) “You have to stop treating psoriasis as just a skin disease”. In Switzerland, psoriasis affects about 1 to 3 percent of the population [1]. About one in three psoriasis patients also suffers from psoriatic arthritis (PsA), a chronic inflammatory systemic disease that…
View Post 7 min This content is machine translated Sponsored Content: Extra-musculoskeletal manifestations in rheumatic diseases Rheumatic diseases and their connection to the gut Patients with spondyloarthropathies (SpA) often suffer from extra-musculoskeletal manifestations (EMMs), which can also affect the gut [1, 2]. These multifaceted diseases with a complex clinical picture have both physiological and…
View Post 4 min This content is machine translated TYK2 inhibition in psoriasis What’s new? The JAK-STAT pathway mediates a variety of proinflammatory responses through Janus kinases (JAK)1-3 andtyrosine kinase-2 (TYK2).Deucravacitinib selectively inhibits TYK2 and was shown to be effective and safe in patients with…
View Post 4 min This content is machine translated IL-23-i for psoriasis Real-world studies with a focus on PROs Individual therapy goals are playing an increasingly important role in the modern, guideline-oriented treatment of psoriasis. In this context, real-world studies with biologics often not only record the reduction in…
View Post 5 min This content is machine translated Rare diseases Muckle-Wells syndrome This rare autoinflammatory syndrome, caused by a genetic mutation, was first described in 1962 by the English doctors Thomas James Muckle and Michael Vernon Wells. Muckle-Wells syndrome is one of…
View Post 3 min This content is machine translated IL-17A inhibitors for nail psoriasis 1-year data from the PsoHo study The “Psoriasis Study of Health Outcomes” (PSoHO) is an international, prospective, non-interventional cohort study. In the meantime, new interim analyses have been published of study participants who had nail infestation…
View Post 4 min This content is machine translated Joint hypermobility When excessive mobility becomes a problem The 2017 international classification replaces previous terms for symptomatic joint hypermobility. Ehlers-Danlos syndrome (EDS) and hypermobility spectrum disorder (HSD) are clinical diagnoses. The primary therapeutic goals are to alleviate the…
View Post 4 min This content is machine translated Forum Infectiology: Lyme borreliosis There are several myths surrounding borrelia Lyme borreliosis was named after the small US town of Lyme after a strikingly high incidence of cases of joint inflammation following tick bites in the mid-1970s. It turned out…
